Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function

被引：0

作者：

S. L. Wong

S. Menacherry

D. Mulford

P. J. Schmitz

C. Locke

G. R. Granneman

机构：

[1] Department of Pharmacokinetics and Biopharmaceutics,

[2] D4PK,undefined

[3] AP 13A,undefined

[4] Abbott Laboratories,undefined

[5] 100 Abbott Park Road,undefined

[6] Abbott Park,undefined

[7] IL 60064-3500,undefined

[8] USA Tel. +1-847-938-0312; Fax +1-847-938-5193; e-mail shekman.wong@abbott.com,undefined

[9] Drug Analysis Department,undefined

[10] Abbott Laboratories,undefined

[11] USA,undefined

[12] Biotransformation Department,undefined

[13] Abbott Laboratories,undefined

[14] USA,undefined

[15] Psychopharmacology Venture,undefined

[16] Abbott Laboratories,undefined

[17] USA,undefined

[18] Biostatistics Department,undefined

[19] Abbott Laboratories,undefined

[20] USA,undefined

来源：

European Journal of Clinical Pharmacology | 1997年 / 52卷

关键词：

Key words Sertindole; Renal impairment; pharmacoki netics; hemodialysis; schizophrenia; antipsychotics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective: To study the effect of renal impairment on the pharmacokinetics of sertindole.

引用

页码：223 / 227

页数：4

共 42 条

[21] Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers
Krueger, M
Achenbach, H
Terhaag, B
Haase, H
Richter, K
Oertel, R
Preiss, R
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (02) : 61 - 66
[22] Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal function
Harenberg, Job
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : S10 - S13
[23] PHARMACOKINETICS OF CIPROFLOXACIN IN SUBJECTS WITH VARYING DEGREES OF RENAL-FUNCTION AND UNDERGOING HEMODIALYSIS OR CAPD
KOWALSKY, SF
ECHOLS, M
SCHWARTZ, MT
BAILIE, GR
MCCORMICK, E
CLINICAL NEPHROLOGY, 1993, 39 (01) : 53 - 58
[24] Gadobenate Dimeglumine Administration and Nephrogenic Systemic Fibrosis: Is There a Real Risk in Patients with Impaired Renal Function?
Nandwana, Sadhna B.
Moreno, Courtney C.
Osipow, Michael T.
Sekhar, Aarti
Cox, Kelly L.
RADIOLOGY, 2015, 276 (03) : 741 - 747
[25] Impaired renal function is an independent risk factor for complications after surgery for femoral neck fracture
Ramamurti, Pradip
Fassihi, Safa C.
Sacolick, David
Gu, Alex
Wei, Chapman
Chodos, Marc D.
HIP INTERNATIONAL, 2023, 33 (02) : 345 - 353
[26] Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease
Pawlak, Krystyna
Pawlak, Dariusz
Mysliwiec, Michal
CLINICAL BIOCHEMISTRY, 2007, 40 (1-2) : 81 - 85
[27] Pharmacokinetics of the Long-Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal Function
Linnebjerg, Helle
Choi, Siak Leng
Lam, Eric Chen Quin
Mace, Kenneth F.
Hodgson, Teri S.
Sinha, Vikram P.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (03): : 216 - 224
[28] Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation
Horvatits, T.
Pischke, S.
Proske, V. M.
Fischer, L.
Scheidat, S.
Thaiss, F.
Fuhrmann, V.
Lohse, A. W.
Nashan, B.
Sterneck, M.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (01) : 104 - 111
[29] Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature
Cossu, A. P.
Musu, M.
Mura, P.
De Giudici, L. M.
Finco, G.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 23 - 28
[30] HEMODIALYSIS FOR ELIMINATION OF THE NONIONIC CONTRAST-MEDIUM IOHEXOL AFTER ANGIOGRAPHY IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
MOON, SS
BACK, SE
KURKUS, J
NILSSONEHLE, P
NEPHRON, 1995, 70 (04): : 430 - 437

← 1 2 3 4 5 →